#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Christopher Barnum Email
VP CNS Development . inmunebio.com
How to contact Christopher Barnum
Join and see Christopher's contact info for free!Phone
Current Roles
Employees:
28Revenue:
$4.3MAbout
INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient's immune system to treat cancer. INKmune, the company's lead product, primes patient's NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease. Media coverage provided for informational purposes only and third party links provided as a resource. INmune Bio does not control the content of third parties. XPro1595, Quellor, LIVNate, INB03, INKmune and other drug candidates, have not yet been shown to be safe or effective, and has not been approved by any regulatory body.inmunebio.com Address
225 NE Mizner BlvdLa Jolla, CA
United States